{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:04:50Z","timestamp":1778223890723,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cardiacep.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ccep.2023.04.001","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T15:22:06Z","timestamp":1685200926000},"page":"249-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Implantable Devices in Genetic Heart Disease"],"prefix":"10.1016","volume":"15","author":[{"given":"Simon","family":"Hansom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Laksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ccep.2023.04.001_bib1","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.ccep.2023.04.001_bib2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.hrthm.2011.01.048","article-title":"Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia","volume":"8","author":"Sy","year":"2011","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.ccep.2023.04.001_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.hrthm.2013.10.027","article-title":"Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia","volume":"11","author":"Roses-Noguer","year":"2014","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.ccep.2023.04.001_bib4","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.hrthm.2018.06.046","article-title":"Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: a systematic review","volume":"15","author":"Roston","year":"2018","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.ccep.2023.04.001_bib5","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/europace\/euz065","article-title":"HRS\/EHRA\/APHRS\/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"21","author":"Stiles","year":"2019","journal-title":"EP Europace"},{"issue":"5","key":"10.1016\/j.ccep.2023.04.001_bib6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.hroo.2020.10.002","article-title":"Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from\u00a0the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes","volume":"1","author":"Lambiase","year":"2020","journal-title":"Heart rhythm O2"},{"issue":"4","key":"10.1016\/j.ccep.2023.04.001_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacep.2021.12.002","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Krahn","year":"2022","journal-title":"Clinical Electrophysiology"},{"issue":"2","key":"10.1016\/j.ccep.2023.04.001_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/heartjnl-2021-319113","article-title":"Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification","volume":"108","author":"Bosman","year":"2022","journal-title":"Heart"},{"issue":"15","key":"10.1016\/j.ccep.2023.04.001_bib9","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/CIRCULATIONAHA.118.037230","article-title":"Sudden death and left ventricular involvement in arrhythmogenic cardiomyopathy","volume":"139","author":"Miles","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2023.04.001_bib10","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","article-title":"A\u00a0new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"40","author":"Cadrin-Tourigny","year":"2019","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ccep.2023.04.001_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2014.04.035","article-title":"Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment","volume":"64","author":"Link","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.ccep.2023.04.001_bib12","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/01.CIR.0000103130.33451.D2","article-title":"Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"108","author":"Corrado","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ccep.2023.04.001_bib13","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.hrthm.2021.04.028","article-title":"Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: insights from the Johns Hopkins ARVC Program","volume":"18","author":"Daimee","year":"2021","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.ccep.2023.04.001_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.15420\/aer.2016:30:2","article-title":"ICD therapy for primary prevention in hypertrophic cardiomyopathy","volume":"5","author":"Trivedi","year":"2016","journal-title":"Arrhythmia Electrophysiol Rev"},{"issue":"7","key":"10.1016\/j.ccep.2023.04.001_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ccep.2023.04.001_bib16","first-page":"e008123","article-title":"Long-term outcome in high-risk patients with hypertrophic cardiomyopathy after primary prevention defibrillator implants","volume":"13","author":"Rowin","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ccep.2023.04.001_bib17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jce.13005","article-title":"Appropriate implantable defibrillator therapy in adults with hypertrophic cardiomyopathy","volume":"27","author":"Thavikulwat","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"25","key":"10.1016\/j.ccep.2023.04.001_bib18","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccep.2023.04.001_bib19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.hrthm.2020.02.024","article-title":"Antitachycardia pacing for shock prevention in patients with hypertrophic cardiomyopathy and ventricular tachycardia","volume":"17","author":"Dallaglio","year":"2020","journal-title":"Heart Rhythm"},{"issue":"25","key":"10.1016\/j.ccep.2023.04.001_bib20","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","article-title":"Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy","volume":"136","author":"Rowin","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccep.2023.04.001_bib21","doi-asserted-by":"crossref","first-page":"e002488","DOI":"10.1161\/JAHA.115.002488","article-title":"Subcutaneous implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy: an initial experience","volume":"5","author":"Weinstock","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.ccep.2023.04.001_bib22","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.hrthm.2016.01.001","article-title":"Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts","volume":"13","author":"Lambiase","year":"2016","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.ccep.2023.04.001_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.hrthm.2022.01.013","article-title":"Subcutaneous versus transvenous implantable defibrillator in patients with hypertrophic cardiomyopathy","volume":"19","author":"Jankelson","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2023.04.001_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/pace.13665","article-title":"Safety and efficacy of anti-tachycardia pacing in patients with hypertrophic cardiomyopathy implanted with an ICD","volume":"42","author":"Adduci","year":"2019","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ccep.2023.04.001_bib25","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCGENETICS.109.853374","article-title":"SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome","volume":"2","author":"Probst","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"10.1016\/j.ccep.2023.04.001_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pcad.2008.05.002","article-title":"Brugada syndrome","volume":"51","author":"Benito","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.ccep.2023.04.001_bib27","first-page":"267","article-title":"Worldwide prevalence of Brugada syndrome: a systematic review and meta-analysis","volume":"34","author":"Vutthikraivit","year":"2018","journal-title":"Acta Cardiol Sin"},{"issue":"9","key":"10.1016\/j.ccep.2023.04.001_bib28","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jacc.2014.12.031","article-title":"Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience","volume":"65","author":"Conte","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccep.2023.04.001_bib29","first-page":"141","article-title":"Meta-analysis of clinical outcome after implantable cardioverter-defibrillator implantation in patients with Brugada syndrome","volume":"5","author":"Dereci","year":"2019","journal-title":"JACC (J Am Coll Cardiol): Clinical Electrophysiology"},{"issue":"4","key":"10.1016\/j.ccep.2023.04.001_bib30","first-page":"792","article-title":"T-wave oversensing in patients with Brugada syndrome: true bipolar versus integrated bipolar implantable cardioverter defibrillator leads: multicenter retrospective study","volume":"8","author":"Rodr\u00edguez-Ma\u00f1ero","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccep.2023.04.001_bib31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/europace\/euab230","article-title":"Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study","volume":"24","author":"Conte","year":"2022","journal-title":"EP Europace"},{"key":"10.1016\/j.ccep.2023.04.001_bib32","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/europace\/eux009","article-title":"High rate of subcutaneous implantable cardioverter-defibrillator sensing screening failure in patients with Brugada syndrome: a comparison with other inherited primary arrhythmia syndromes","volume":"20","author":"Conte","year":"2018","journal-title":"Europace"},{"issue":"12","key":"10.1016\/j.ccep.2023.04.001_bib33","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/jce.13315","article-title":"Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome","volume":"28","author":"Tachibana","year":"2017","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"1","key":"10.1016\/j.ccep.2023.04.001_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00392-009-0075-4","article-title":"Prevention of inappropriate ICD shocks in patients with Brugada syndrome","volume":"99","author":"Veltmann","year":"2010","journal-title":"Clin Res Cardiol"},{"issue":"14","key":"10.1016\/j.ccep.2023.04.001_bib35","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/CIRCULATIONAHA.113.003985","article-title":"Long QT syndrome","volume":"129","author":"Abrams","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccep.2023.04.001_bib36","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/01.CIR.84.3.1136","article-title":"The long QT syndrome. Prospective longitudinal study of 328 families","volume":"84","author":"Moss","year":"1991","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ccep.2023.04.001_bib37","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2023.04.001_bib38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jacep.2022.02.017","article-title":"Congenital long QT syndrome","volume":"8","author":"Krahn","year":"2022","journal-title":"Clinical Electrophysiology"},{"issue":"1","key":"10.1016\/j.ccep.2023.04.001_bib39","first-page":"91","article-title":"The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention","volume":"6","author":"Olde Nordkamp","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccep.2023.04.001_bib40","first-page":"183","article-title":"Mortality of inherited arrhythmia syndromes: insight into their natural history","volume":"5","author":"Nannenberg","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccep.2023.04.001_bib41","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1540-8167.2000.tb00015.x","article-title":"Cardiac pacing in the long QT syndrome: review of available data and practical recommendations","volume":"11","author":"Viskin","year":"2000","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"3","key":"10.1016\/j.ccep.2023.04.001_bib42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/jce.14920","article-title":"Efficacy of intentional permanent atrial pacing in the long-term management of congenital long QT syndrome","volume":"32","author":"Kowlgi","year":"2021","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"7","key":"10.1016\/j.ccep.2023.04.001_bib43","first-page":"918","article-title":"Short-coupled idiopathic ventricular fibrillation-a literature review with extended follow-up","volume":"8","author":"Belhassen","year":"2022","journal-title":"JACC (J Am Coll Cardiol)"},{"issue":"11","key":"10.1016\/j.ccep.2023.04.001_bib44","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/europace\/euz221","article-title":"Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: results from a multicentre long-term registry","volume":"21","author":"Conte","year":"2019","journal-title":"EP Europace"},{"issue":"38","key":"10.1016\/j.ccep.2023.04.001_bib45","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1093\/eurheartj\/ehab614","article-title":"Quinidine vs. ICD therapy in short-coupled ventricular fibrillation\u2014is a randomized trial the next logical step?","volume":"42","author":"Steinberg","year":"2021","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ccep.2023.04.001_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10840-016-0143-4","article-title":"Long-time \u201creal-life\u201d performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation","volume":"47","author":"Frommeyer","year":"2016","journal-title":"J\u00a0Intervent Card Electrophysiol"},{"issue":"7","key":"10.1016\/j.ccep.2023.04.001_bib47","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2010.09.048","article-title":"The short QT syndrome: proposed diagnostic criteria","volume":"57","author":"Gollob","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccep.2023.04.001_bib48","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/CIRCULATIONAHA.106.676551","article-title":"Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population","volume":"116","author":"Anttonen","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccep.2023.04.001_bib49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jacc.2011.03.037","article-title":"Proposed diagnostic criteria for short QT syndrome are badly founded","volume":"58","author":"Bjerregaard","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccep.2023.04.001_bib50","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2011.03.038","article-title":"Long-term follow-up of patients with short QT syndrome","volume":"58","author":"Giustetto","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ccep.2023.04.001_bib51","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1177\/2047487319850953","article-title":"Sex-differences in short QT syndrome: a systematic literature review and pooled analysis","volume":"27","author":"El-Battrawy","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"10.1016\/j.ccep.2023.04.001_bib52","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1046\/j.1540-8167.2003.03278.x","article-title":"Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery","volume":"14","author":"Schimpf","year":"2003","journal-title":"J\u00a0Cardiovasc Electrophysiol"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918223000382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918223000382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:42:58Z","timestamp":1761802978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918223000382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1877918223000382"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2023.04.001","relation":{},"ISSN":["1877-9182"],"issn-type":[{"value":"1877-9182","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implantable Devices in Genetic Heart Disease","name":"articletitle","label":"Article Title"},{"value":"Cardiac Electrophysiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccep.2023.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}